Codex DNA Releases New Synthetic Genomes for the Fight Against COVID-19

Codex DNA, Inc. today announced the release of seven new synthetic SARS-CoV-2 genomes for use in the development of vaccines, therapeutics, and diagnostics to help in the COVID-19 pandemic response.